药代动力学
广告
药物输送
药理学
离体
药品
体内
医学
化学
生物
生物技术
有机化学
作者
Patrick M. Glassman,Carlos H. Villa,Anvay Ukidve,Zongmin Zhao,Paige N. Smith,Samir Mitragotri,Alan J. Russell,J. Brenner,Vladimir R. Muzykantov
出处
期刊:Pharmaceutics
[Multidisciplinary Digital Publishing Institute]
日期:2020-05-09
卷期号:12 (5): 440-440
被引量:57
标识
DOI:10.3390/pharmaceutics12050440
摘要
Red blood cells (RBC) have great potential as drug delivery systems, capable of producing unprecedented changes in pharmacokinetics, pharmacodynamics, and immunogenicity. Despite this great potential and nearly 50 years of research, it is only recently that RBC-mediated drug delivery has begun to move out of the academic lab and into industrial drug development. RBC loading with drugs can be performed in several ways—either via encapsulation within the RBC or surface coupling, and either ex vivo or in vivo—depending on the intended application. In this review, we briefly summarize currently used technologies for RBC loading/coupling with an eye on how pharmacokinetics is impacted. Additionally, we provide a detailed description of key ADME (absorption, distribution, metabolism, elimination) changes that would be expected for RBC-associated drugs and address unique features of RBC pharmacokinetics. As thorough understanding of pharmacokinetics is critical in successful translation to the clinic, we expect that this review will provide a jumping off point for further investigations into this area.
科研通智能强力驱动
Strongly Powered by AbleSci AI